1-10 of 10
Christopher Fox
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib plus rituximab leads to superior progression-free and overall survival to FCR in previously untreated CLL: Results of the Phase III NCRI FLAIR trial

Free
Talha Munir, Sean Girvan, Annah Muli, David Cairns, David Allsup, Adrian Bloor, Abraham Mullasseril Varghese, Angus Broom, Moya Young, Ben Kennedy, Renata Walewska, Michelle Furtado, Gavin Preston, Jeffrey Neilson, Nicholas Pemberton, Gamal Sidra, Nick Morley, Kate Cwynarski, Toby Eyre, Francesco Forconi, Simona Gatto, Shankara Paneesha, Christopher Fox, Dena Howard, Anna Hockaday, Julia Brown, Sharon Jackson, David Stones, Sue Bell, Natasha Greatorex, Nichola Webster, Jane Shingles, Surita Dalal, Piers Patten, Andy Rawstron, Peter Hillmen
Journal: Blood
Blood (2025) 146 (Supplement 1): 2128.
https://doi.org/10.1182/blood-2025-2128
Published: 2025
Journal Articles

Cancer-selective targeting of the NF-κB pathway via GADD45β/MKK7 inhibition: Results from the phase I trial of the first-in-class inhibitor, DTP3, in patients with relapsed or refractory multiple myeloma

Free
Aristeidis Chaidos, Dimitrios Potolidis, Jessica Cornice, Holger Auner, Gary Acton, Ceri Bygrave, Gordon Cook, Rakesh Popat, Andrew Davies, Christopher Parrish, Maria Atta, Kim Linton, Dean Smith, Christopher Fox, Iain McNeish, Elizabeth Hadley, Elena Ferrer Martinez Del Peral, Mario Pellegatti, Nigel Adams, Albert Chau, Precious Nnebedum, Daria Capece, Daniela Verzella, Daniel D'Andrea, Jan Rekowski, Christina Yap, Laura Tornatore, Guido Franzoso
Journal: Blood
Blood (2025) 146 (Supplement 1): 5825.
https://doi.org/10.1182/blood-2025-5825
Published: 2025
Journal Articles

Sustained clinical benefit of glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab plus GemOx (R-GemOx) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 3-year follow-up of STARGLO

Free
Jeremy Abramson, Matthew Ku, Christopher Fox, Huiqiang Huang, Huilai Zhang, William Townsend, Dok Hyun Yoon, Won-Seog Kim, Haifaa Abdulhaq, Charles Herbaux, Jan Zaucha, Hung Chang, Estefania Mulvihill, Murali Kesavan, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Alessia Bottos, Linda Lundberg, Gareth P. Gregory
Journal: Blood
Blood (2025) 146 (Supplement 1): 5519.
https://doi.org/10.1182/blood-2025-5519
Published: 2025
Journal Articles

Mosunetuzumab (Mosun) or glofitamab (Glofit) in combination with golcadomide (Golca) demonstrates a manageable safety profile and encouraging efficacy in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)

Free
Charalambos Andreadis, Irit Avivi, Neta Goldschmidt, William Townsend, Mariana Bastos-Oreiro, Abraham Avigdor, Peter Riedell, Inna Tzoran, Toby Eyre, Pamela McKay, Pau Abrisqueta, Eva Gonzalez Barca, Alejandro Martin Garcia-Sancho, Sara Galimberti, Antonia Kwan, James Relf, Wilfred Leung, Francis Mussai, Connie Ma, Adrien Petel, Patrick Mueller, Xuefeng Hou, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 66.
https://doi.org/10.1182/blood-2025-66
Published: 2025
Journal Articles

Glofitamab plus gemcitabine and oxaliplatin (GemOx) vs rituximab (R)-GemOx in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Efficacy and safety in patient subgroups

Free
Haifaa Abdulhaq, William Townsend, Matthew Ku, Gareth P. Gregory, Jeremy Abramson, Huiqiang Huang, Huilai Zhang, Dok Hyun Yoon, Won-Seog Kim, Herve Ghesquieres, Mark Hertzberg, Qing-Yuan Zhang, Murali Kesavan, Estefania Mulvihill, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Linda Lundberg, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 3743.
https://doi.org/10.1182/blood-2025-3743
Published: 2025
Journal Articles

Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma: Final results from the phase 2 PRIMO trial - impact of prior therapy and expanded safety analysis

Free
Pier Luigi Zinzani, Neha Mehta-Shah, Jasmine Zain, Giuseppe Gritti, Lauren Pinter-Brown, Koji Izutsu, Ohad S. Bentur, David Sidransky, Jonathan Brammer, Barbara Pro, Christopher Fox, Steven Horwitz
Journal: Blood
Blood (2025) 146 (Supplement 1): 3634.
https://doi.org/10.1182/blood-2025-3634
Published: 2025
Journal Articles

Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery

Free
Louise Stanton, Geoffrey Saunders, Sharon Barrans, Joshua Caddy, Katy McLaughlin, Pamela McKay, Antonina Zhelyazkova, Graham Collins, Christopher Fox, Jamie Wilson, Abigail Morgan-Fox, Jackie Raftery, Julie Richardson-Abraham, Oliver Seymour, Katie Mansell, Tracey Mell, Moniek Van Hoppe, Alessandra Serra, Gareth Griffiths, Victoria Warbey, Vivek Radhakrishnan, Pavel Mozgunov, Sally Barrington, Cathy Burton, Peter Johnson, Andrew Davies
Journal: Blood
Blood (2025) 146 (Supplement 1): 5459.
https://doi.org/10.1182/blood-2025-5459
Published: 2025
Journal Articles

Treatment intensity and region of diagnosis affect survival in primary CNS lymphoma in England: A national cohort study from the uncover project.

Free
Mark Bishton, Nurunnahar Akter, indrani karpha, Sarrah Tayabali, Temitope Erinfolami, Catrin Tudur Smith, Hanhua Liu, Yeong Jer Lim, Brogan Johnston, Jeffery Smith, Kate Cwynarski, David Howarth, Nagesh Kalakonda, Andrew Pettitt, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 6325.
https://doi.org/10.1182/blood-2025-6325
Published: 2025
Journal Articles

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Free
David Burns, Shabeeha Rana, Andrew Howman, Sandeep Nagra, Janice Ward, Husam Osman, Yusri Taha, Jenny Byrne, Emma Das-Gupta, Manoj Raghavan, Ram Malladi, Mark Cook, Prem Mahendra, Nigel H. Russell, MD, Charles Craddock, Christopher Fox, Sridhar Chaganti
Journal: Blood
Blood (2012) 120 (21): 460.
https://doi.org/10.1182/blood.V120.21.460.460
Published: 2012
Journal Articles

A Single-Centre Series of 40 Patients with Bone-Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia; High Rates of Sustained Response to Oral Methotrexate

Free
Christopher Fox, MBChB, MRCP, FRCPath, Talha Munir, MBBS, MRCP, FRCPath, Ian Carter, Sturch Elaine, Faith Richardson, Andrew McMillan, FRCP, FRCPath, PhD, Simon O'Connor, MBChB, FRCP, FRCPath, Andrew Haynes, MBChB, FRCP, FRCPath
Journal: Blood
Blood (2012) 120 (21): 3937.
https://doi.org/10.1182/blood.V120.21.3937.3937
Published: 2012